Amicus Therapeutics (FOLD) PT Lowered to $14 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 21 | New: 0
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 21 | New: 0
Join SI Premium – FREE
BTIG analyst Yun Zhong lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $14.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Aixtron SE (AIXA:GR) (AIXXF) to Overweight
- Banco de Sabadell SA (SAB:SM) (BNDSF) PT Raised to EUR3.60 at Morgan Stanley
- Sandvik AB (SAND:SS) (SDVKY) PT Raised to SEK443 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
